October 27, 2017 — CorInnova Inc. announced it has received notice of allowance of a seminal patent to protect its ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart ...
October 19, 2017 — African American women were found to be twice as likely to be diagnosed with peripartum ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 18, 2017 — The U.S. Food and Drug Administration (FDA) recently approved a new treatment option for patients who ...
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S. arm of the ALIVE ...
October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a ...
September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) ...
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator ...
September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...
September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...
September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...
September 19, 2017 — The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 6, 2017 — Physicians identified a majority of patients with advanced heart failure as at high risk for ...
September 5, 2017 — Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli ...
August 29, 2017 — Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev ...